Skip to Content

Varian Medical Systems Inc VAR

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat




Siemens Healthineers to Buy Varian; Elekta Next?

Alex Morozov, CFA Regional Director

Analyst Note

| Alex Morozov, CFA |

We have long been enamored with the radiotherapy industry, given its material barriers to entry, highly oligopolistic structure, and robust long-term demand tailwinds. We have awarded wide economic moats to both firms that account for the vast majority of revenue in this space--Varian and Elekta--and have speculated for a while that this highly attractive healthcare niche will eventually appeal to the larger healthcare conglomerates, several of which have previously been involved with radiotherapy. Thus the Aug. 2 announcement of Siemens Healthineers' return to the space via the acquisition of Varian wasn't unexpected. The price that Healthineers is paying for Varian--$177.50 per share, 45% above our stand-alone fair value estimate of $121 per share--fully values this wide-moat firm; Healthineers will have to more than just deliver on its expectation of $300 million in annual synergies for the deal to become value-accretive. Our expectation now is that Elekta should be next; given its long-standing partnership with Royal Philips and historic roots, it wouldn't surprise us if the two come together.

Read Full Analysis

Company Profile

Business Description

Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (19%).

3100 Hansen Way
Palo Alto, CA, 94304-1038
T +1 650 493-4000
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings Jun 30, 2020
Fiscal Year End Sep 27, 2020
Stock Type Slow Growth
Employees 10,062